Leading up to the live event, registrants will receive pre-recorded one-on-one interviews with the industry’s preeminent medical experts, thought leaders and CEO’s beginning on May 27, 2020. These video ‘micro sessions’ will provide insights into the history of psychedelics in medicine, current clinical applications and the business models poised to seize market share.
Micro Sessions Agenda
Each week registrants will receive one on one interviews with thought leaders in the psychedelics space, where they can gain insight into the history, application and future of the sector.
Richard Carleton , CEO of the Canadian Securities Exchange, discusses this emerging sector and how to navigate it through listings and the capital markets.
Bruce Linton , Founder and former chairman at Canopy Growth, discusses the space and its opportunities.
Dr. Dennis McKenna, Director of ethnopharmacology at the Heffter Research Institute, provides an in-depth overview of the history of psychedelics.
Dr. Roger McIntyre, CEO of Champignon Brands, gives an in-depth preview to the application of psychedelics and their therapeutic uses.
Dr. Nikos C. Apostolopoulos, CSO of AlphaMind Brands talks about therapeutic applications and AlphaMind’s recent acquisition by Hollister Biosciences (CSE: HOLL).
CEO Clips from each of the participating companies. This is your chance to get to know the participating companies and explore some of the pioneering work they’re doing in the world of neuro-pharmaceuticals.
Also, check out our event Virtual Industry Updates: The Rise of the Psychedelics Sector in partnership with MNP LLP and Aird & Berlis LLP coming up on June 10th.
June 17th Investing in Psychedelics LIVE EVENT!
A full afternoon of panel discussions amongst bankers, thought leaders and participating companies.
Bankers / Brokers
- TCF – Henri Sant-Cassia (Founding Partner)
- Haywood Securities – Bill O’Hara (CFA & Managing Director)
- CSE – Richard Carleton (CEO)